Anavex Life Sciences Corp (AVXL)

[Gator328]

If it's going to be delayed anyway because the FDA requires another P3 trial, I'd rather see the company shift its immediate attention to Rett.

Even if we have stellar data, where's your evidence that the FDA is going to drop everything to work with Anavex for accelerated approval? There's finite manpower at the FDA. We could be waiting in line with our Alzheimer's NDA for months or longer, no matter how excellent the data may be.